The Biden administration announced Thursday that it has reached a deal to buy 10 million courses of Pfizer’s COVID-19 treatment.
So, why do these pills cost $500? If you wonder about all the misinformation about Ivermectin, here may be your answer. Clinical evidence finds that large reductions in COVID-19 deaths are possible using ivermectin. Using ivermectin early in the clinical course may reduce numbers progressing to severe disease. The apparent safety and low cost suggest that ivermectin is likely to have a significant impact on the SARS-CoV-2 pandemic globally. Given cases have plunged over 50% since September, why do we need a $500 pill when you can use ivermectin for about $1?
The $5.29 billion deal will allow for the first deliveries of the pills to be made this year, with the order concluding next year.
Pfizer’s pill, known as Paxlovid, has been shown to be very promising in trials, reducing the risk of hospitalization or death by 89 percent.
The drug still needs to be authorized by the Food and Drug Administration before it can be used. Pfizer applied for authorization earlier this week.
The company also announced a deal this week to share the formula for the pill to allow low-income countries to make it.
Wonder who owns large amounts of stock in Pfizer and the other COVID experimental drug companies? Pelosi, Biden, Fauci?